Survey explores the industry's economic impact and what the fastest-growing middle market life sciences organizations do differently to overcome hurdles and sustain growth
- Net loss was $(331) million versus net income of $1,150 million prior year, and core operating loss was $(254) million versus core operating income of $1,195 million prior year.